DESTINEY HENRY: Open Payments
NPI 1811473739 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 6 payments from 5 companies in 2025. Trend: 2023 $902 · 2024 $468 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $244 |
| AKEBIA THERAPEUTICS INC | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Calliditas Therapeutics US Inc. | 1 | $28 |
Products named: KRYSTEXXA, Vafseo, AUSTEDO XR, Fabhalta, TARPEYO.
Industry payments across LA — which companies pay providers there.
